JP3534933B2 - External composition for skin - Google Patents

External composition for skin

Info

Publication number
JP3534933B2
JP3534933B2 JP04053996A JP4053996A JP3534933B2 JP 3534933 B2 JP3534933 B2 JP 3534933B2 JP 04053996 A JP04053996 A JP 04053996A JP 4053996 A JP4053996 A JP 4053996A JP 3534933 B2 JP3534933 B2 JP 3534933B2
Authority
JP
Japan
Prior art keywords
skin
effect
composition
mevalonic acid
component
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP04053996A
Other languages
Japanese (ja)
Other versions
JPH09208419A (en
Inventor
明男 後藤
Original Assignee
カネボウ株式会社
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by カネボウ株式会社 filed Critical カネボウ株式会社
Priority to JP04053996A priority Critical patent/JP3534933B2/en
Publication of JPH09208419A publication Critical patent/JPH09208419A/en
Application granted granted Critical
Publication of JP3534933B2 publication Critical patent/JP3534933B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Cosmetics (AREA)

Description

【発明の詳細な説明】 【0001】 【発明の属する技術分野】本発明は、老化防止効果(荒
れ肌改善効果、角質改善効果、ターンオーバー速度を早
くする効果)、美肌効果を発現、付与し得る皮膚外用組
成物に関する。 【0002】 【従来の技術】老化した皮膚は、乾燥して滑らかさのな
い荒れ肌となり、角質細胞剥離現象が認められる。そし
て、老化皮膚は、ターンオーバー速度が遅く、皮膚に老
化防止効果が発現、付与されると、皮膚のターンオーバ
ー速度が早くなると言われている。従来、皮膚表面に適
度な湿潤感及び柔軟性を与える化粧料は種々提案され、
例えば特開平4−99707号では、R−(−)メバロ
ン酸を含有する皮膚化粧料が提案されている。しかし、
これらの化粧料は上記の様な皮膚の老化防止に十分な効
果を有するものではなかった。 【0003】 【発明が解決しようとする課題】本発明の目的は、老化
防止効果(荒れ肌改善効果、角質改善効果、ターンオー
バー速度を早くする効果)、及び美肌効果を発現、付与
し得る優れた皮膚外用組成物を提供することにある。 【0004】 【課題を解決するための手段】上記の目的は、(a)メ
バロン酸、メバロン酸ラクトンから選ばれる一種以上
0.001〜10重量%と、(b)セラミドガラクト
シルセラミド、スフィンゴミエリンから選ばれる一種以
を0.001〜3.0重量%とを含有する皮膚外用組
成物によって達成される。 【0005】 【発明の実施の形態】本発明で(a)成分しとて使用す
るメバロン酸は火落酸(分子式:C6 124 )とも言
い、清酒中に混入した真性火落菌(Lactobaci
llus homohiochi、及びL.heter
ohiochi)の不可欠生育因子、及び乳酸菌(L.
acidophillus)の生育促進因子として発見
された物質であり、ステロール等のイソプレノイド系化
合物の生合成前駆体、または各種光学活性物質の化学的
もしくは酵素的合成原料に利用される。そしてメバロン
酸には、2種類の異性体〔R(−)−メバロン酸、S
(+)−メバロン酸〕があり、天然に存在するのはR
(−)−メバロン酸であるが、本発明には、その何れも
使用できるが、入手が容易なR(−)−メバロン酸が好
ましい。R(−)−メバロン酸は、例えば、特開昭63
−216484号、特開昭63−216485号、特開
昭63−216486号、特開昭63−216487等
に記載された微生物発酵方法によって製造できる。また
は、化学的合成方法によってラセミ体(異性体混合物)
としても得られ、各異性体として分離も可能である。ま
た、本発明で(b)成分として使用するメバロン酸の誘
導体であるメバロン酸ラクトン(分子式:C6
103 )は、加水分解によって容易にメバロン酸に変化
する性質を有する化合物である 【0006】一方、本発明で(b)成分として使用する
セラミドガラクトシルセラミド、スフィンゴミエリン
は人、豚、牛、馬、羊等の哺乳動物の表皮に微量存在す
る化合物であって、バイオケミストリー・アンド・フィ
ジオロジー・オブ・ザ・スキン、第363頁〜第381
頁(Biochemistryand Psysiol
ogy of the Skin,Oxford Un
iversity Press,Inc.,1988,
New York)、及びジャーナル・オブ・リピッド
・リサーチ、第24巻、1983年、第131頁〜第1
40頁(Journal of Lipid Rese
arch)等に記載の製造方法にて得ることができる。
例えば、以下の方法で製造することができる。すなわ
ち、原料となる牛脳を細切後、アセトンを添加したポリ
トロンにてホモジュネートを調製する。不純物を濾別
後、クロロホルム:メタノール(2:1)を添加、一夜
放置後、抽出液を減圧乾固する。次いで、冷アセトンに
抽出液を懸濁させ、4℃で一夜放置後、沈渣を得る。冷
エーテルにて同様の操作で沈渣を得る。そしてケイ酸カ
ラムクロマトグラフィー(クロロホルム:メタノール=
2:1)によりガラクトシルセラミドを得ることができ
る。 【0007】また上記中のガラクトシルセラミド
離後、溶媒をクロロホルム:メタノール(1:2)にす
ることにより、スフィンゴミエリンを得ることができ
る。これをエーテル:エタノール(98:2)に溶解
後、100mMトリス塩酸緩衝液及びホスホリパーゼC
(シグマ社製)を加え、30℃で3時間振盪する。その
後、クロロホルム:メタノール(2:1)を添加し攪
拌、遠心し、下層を減圧乾固する。乾固物よりケイ酸カ
ラムクロマトグラフィー(クロロホルム:メタノール=
9:1)によってセラミドを分離して得ることができ
る。尚、本発明に使用する(b)成分としては、上記の
方法以外に化学的合成方法により得られたもの、あるい
は哺乳動物、植物、または微生物か得られ、上記(b)
成分の一種以上を含有する脂質混合物も本発明の(b)
成分として使用できる。 【0008】本発明の皮膚外用組成物への(a)成分の
メバロン酸、メバロン酸ラクトンのの一種以上の配合量
は、その皮膚外用組成物の総量を基準として0.00
1〜10重量%(以下wt%と略記する。)である。ま
た(b)成分のセラミドガラクトシルセラミド、スフ
ィンゴミエリンの一種以上の配合量は0.001〜
3.0wt%の範囲内である。 【0009】本発明の皮膚外用組成物の剤型は、特に限
定されるものでなく、クリーム状、乳液状、ローション
状、軟膏状、パウダー状等々の通常の皮膚外用組成物の
剤型を適用することができる。本発明の皮膚外用組成物
には、他の成分として、乳化剤、油性物質、保湿剤、香
料、防腐剤、抗酸化剤、着色剤等を本発明の目的を達成
する範囲内で適宜配合し得る。 【0010】 【実施例】以下、実施例及び比較例に基づいて本発明を
詳細に説明する。尚、実施例に記載の(1)角質層のタ
ーンオーバー速度測定方法、(2)荒れ肌改善効果の測
定方法、(3)角質改善効果の測定方法、(4)官能テ
ストは下記の通りである。 【0011】(1)角質層のターンオーバー速度測定方
法 蛍光色素のダンシルクロリドを白色ワセリン中に5wt
%配合した軟膏を作り、被験者20名の前腕部の皮膚に
24時間閉塞塗布し、角質層にダンシルクロリドを浸透
結合させた。その後、同じ部位に1日2回(朝、夕)被
験試料を塗布し、毎日ダンシルクロリドの蛍光を調べ、
その蛍光が消滅するまでの日数を皮膚角質層のターンオ
ーバー速度とした。測定結果は各被験者の日数の平均値
で示した。尚、通常の皮膚角質層のターンオーバーは1
4〜16日であるが、老化した皮膚においては18日前
後に延びる。それに対して老化防止効果が現れると12
日前後にまで短縮される。 【0012】(2)荒れ肌改善効果の測定方法 下脚に荒れ肌を有する中高年被験者20名を対象として
4週間連続塗布効果を調べた。即ち、被験者の左側下脚
試験部位に1日2回(朝、夕)被験試料を塗布し、試験
開始前および終了後の皮膚の状態を下記表1の判定基準
により判定した。尚、右側下脚は被験試料を塗布せず対
照とした。 【0013】 【表1】 【0014】そして試験前後の試験部位と対照部位の判
定結果を比較し、皮膚乾燥度が2段階以上改善された場
合(例えば:+→−、++→±)を「有効」、1段階改
善された場合を「やや有効」、変化がなかった場合を
「無効」とした。試験結果は「有効」、「やや有効」と
なった被験者の人数で示した。 【0015】(3)角質改善(角質細胞の抗剥離性増
大)効果の測定方法 前記の荒れ肌改善測定試験開始前後及び終了後の被験部
皮膚にスコッチテープ(ニチバン社メンディングテー
プ)を接着し、これを剥離したときテープに付着した角
質細胞の状態を走査型電子顕微鏡によって詳細に調べ、
下記表2の判定基準によって皮膚角質層細胞剥離性を分
類し、角質改善効果を求めた。 【0016】 【表2】 【0017】判定は4週間連続塗布後の試験部位の評価
点と対照部位のそれとの差が2点以上の場合を「有
効」、1点以上の場合を「やや有効」、0点の場合を
「無効」とした。試験結果は「有効」、「やや有効」と
なった被験者の人数で示した。 【0018】(4)官能テスト(美肌効果試験) 荒れ肌、小じわ、乾燥肌等を訴える女子被験者(35〜
55才)20人に被験試料を1日2回(朝、夕)連続3
ケ月間塗布して、1、2、3ケ月後の効果を評価した。
試験結果は、皮膚の湿潤性、平滑性、弾力性の各項目に
対して、「皮膚に潤いが生じた」、「皮膚が滑らかにな
った」、「皮膚に張りが生じた」と回答した人数で示し
た。 【0019】実施例1〜4、比較例1〜6(スキンクリ
ーム) (a)成分のメバロン酸、メバロン酸ラクトンから選ば
れる一種以上と、(b)成分のセラミド、グルコシルセ
ラミド、ガラクトシルセラミド、スフィンゴミエリンか
ら選ばれる一種とを表4に記載の通りに配合し、表3の
組成で各々のスキンクリームを調製し、前記の諸実験を
実施した。 【0020】(1)組成 【表3】【0021】(2)調製方法 上記(A)、(B)成分を各々均一に加熱溶解して温度
を80℃にした後、(B)成分中に(A)成分を注入攪
拌混合する。次いで、攪拌しながら温度を30℃迄冷却
しスキンクリームを調製した。尚、上記スキンクリーム
に配合したR(−)−メバロン酸ラクトンは加水分解に
よりR(−)−メバロン酸と共存していると考えられ
る。 【0022】(3)特性 各スキンクリームの諸試験を実施した結果を表4、5に
示す。 【0023】 【表4】 【0024】 【表5】【0025】表4、5に示す如く、比較例1〜6の
(a)成分のメバロン、メバロン酸ラクトン、あるいは
(b)成分のセラミド、グルコシルセラミド、ガラクト
シルセラミド、スフィンゴミエリンのみを配合したスキ
ンクリームは諸特性において充分なる効果が得られない
が、本発明である実施例1〜4の(a)メバロン酸、メ
バロン酸ラクトンの一種以上と、(b)成分のセラミ
ド、グルコシルセラミド、ガラクトシルセラミド、スフ
ィンゴミエリンから選ばれる一種以上とを併用したスキ
ンクリームは、荒れ肌改善効果、角質改善効果、ターン
オーバー速度を早くする効果、すなわち、皮膚の老化防
止効果において顕著な効果が認められ。また、官能テス
トでも塗布後2ケ月で、湿潤性以外に平滑性、弾力性の
発現、付与に優れる美肌効果を示した。 【0026】実施例5、比較例7〜9(ナリシングオイ
ル) 下記表6の組成により、各々のナリシングオイルを調製
して諸試験を実施した。 【0027】(1)組成 【表6】 【0028】(2)調製方法 上記表6の成分を攪拌し均一に溶解してナリシングオイ
ルを調製した。 【0029】(3)特性 各ナリシングオイルについて官能テストを実施した結果
を表7に示す。 【0030】 【表7】【0031】上記表7から明らかな様に実施例のナリシ
ングオイルは塗布2ケ月後で、良好な美肌効果が得られ
た。また、優れた皮膚老化防止効果(荒れ肌改善効果、
角質改善効果、ターンオーバー速度を早くする効果)を
示した。 【0032】実施例6、比較例10〜12(スキンロー
ション) 下記表8の組成により、各々のスキンローションを調製
して諸試験を実施した。 【0033】(1)組成 【表8】 【0034】(2)調製方法 上記表8の成分を撹拌し均一に溶解してスキンローショ
ンを調製した。 【0035】(3)特性 上記実施例6のスキンローションは比較例10〜12に
比べ、優れた美肌効果と皮膚老化防止効果(荒れ肌改善
効果、角質改善効果、ターンオーバー速度を早くする効
果)を示した。 【0036】実施例7(スキンクリーム) 下記表9の組成にてスキンクリームを調製した。 【表9】【0037】(2)調製方法 表9に記載の(A)成分、及び(B)成分を均一に加熱
溶解して温度を80℃にした。次いで、(A)成分中
に、(B)成分を注入乳化した後、撹拌しながら30℃
まで冷却した。 【0038】実施例8(メイクアップベース) 下記表10の組成にてメイクアップベースを調製した。 【0039】(1)組成 【表10】【0040】(2)調製方法 表10に記載の(A)成分、及び(B)成分を均一に加
熱溶解して温度を80℃にした。次いで、(B)成分を
ホモミキサーにて撹拌しながら、(A)成分を注入乳化
した後、30℃まで冷却した。 【0041】実施例9(スキンミルク) 下記表11の組成にてスキンミルクを調製した。 【0042】(1)組成 【表11】【0043】(2)調製方法 表11に記載の(A)成分、及び(B)成分を均一に加
熱溶解して温度を80℃にした。次いで、(A)成分中
に、(B)成分を注入乳化した後、撹拌しながら30℃
まで冷却した。 【0044】上記実施例7〜9は、優れた皮膚老化防止
効果(荒れ肌改善効果、角質改善効果、ターンオーバー
速度を早くする効果)、美肌効果を示した。 【0045】 【発明の効果】以上記載の如く、本発明が、皮膚老化防
止効果(荒れ肌改善効果、角質改善効果、ターンオーバ
ー速度を速くする効果)、美肌効果に優れた有用な皮膚
外用組成物を提供することは明らかである。
Description: BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention can exhibit and impart an anti-aging effect (effect of improving rough skin, effect of improving keratin, effect of increasing turnover speed) and beautiful skin effect. It relates to a composition for external use on the skin. 2. Description of the Related Art Aged skin becomes rough and dry without smoothness, and keratinocyte exfoliation is observed. It is said that the aging skin has a slow turnover speed, and that when the antiaging effect is exerted and imparted to the skin, the turnover speed of the skin increases. Conventionally, various cosmetics that provide an appropriate moist feeling and flexibility on the skin surface have been proposed,
For example, JP-A-4-99707 proposes a skin cosmetic containing R-(-) mevalonic acid. But,
These cosmetics did not have a sufficient effect on the prevention of skin aging as described above. [0003] The object of the present invention is to provide an excellent antiaging effect (effect of improving rough skin, effect of improving keratin, effect of increasing turnover speed), and excellent skin effect that can exhibit and impart a beautiful skin effect. It is to provide a skin external composition. [0004] The above objects SUMMARY In order to achieve the above, one or more selected from (a) mevalonic acid, mevalonic acid lactone
It is achieved by a skin external composition containing 0.001 to 10% by weight and (b) 0.001 to 3.0% by weight of one or more selected from ceramide , galactosylceramide and sphingomyelin. DETAILED DESCRIPTION OF THE INVENTION The mevalonic acid used as the component (a) in the present invention is also called burned acid (molecular formula: C 6 H 12 O 4 ), Lactobaci
lulus homeochichi, and L. et al. hetero
ohiochi), and lactic acid bacteria (L.
A substance discovered as a growth promoting factor of C. acidophilus, and is used as a precursor for biosynthesis of isoprenoid compounds such as sterols, or as a raw material for chemically or enzymatically synthesizing various optically active substances. Mevalonic acid has two isomers [R (-)-mevalonic acid, S
(+)-Mevalonic acid], and naturally occurring R
Although (-)-mevalonic acid can be used in the present invention, R (-)-mevalonic acid, which is easily available, is preferable. R (-)-mevalonic acid is disclosed in, for example,
216484, JP-A-63-216485, JP-A-63-216486, JP-A-63-216487, and the like. Or racemic form (mixture of isomers) by chemical synthesis
And can be separated as isomers. In addition, mevalonate lactone (molecular formula: C 6 H), which is a derivative of mevalonic acid used as the component (b) in the present invention.
10 O 3 ) is a compound having the property of easily changing to mevalonic acid by hydrolysis. On the other hand, ceramide , galactosylceramide and sphingomyelin used as component (b) in the present invention are human, pig, and cow. A compound which is present in a trace amount in the epidermis of mammals such as horses, sheep, etc., and is referred to as Biochemistry and Physiology of the Skin, pp. 363-381.
Page (Biochemistry and Psysiol)
ogy of the Skin, Oxford Un
inverse Press, Inc. , 1988,
New York), and Journal of Lipid Research, Vol. 24, 1983, pp. 131-1.
Page 40 (Journal of Lipid Rese
arch) and the like.
For example, it can be manufactured by the following method. That is, after the bovine brain as a raw material is minced, homogenate is prepared using a polytron to which acetone has been added. After removing impurities by filtration, chloroform: methanol (2: 1) is added, and the mixture is left overnight, and the extract is dried under reduced pressure. Next, the extract is suspended in cold acetone and left at 4 ° C. overnight to obtain a precipitate. A precipitate is obtained in the same manner with cold ether. And silica column chromatography (chloroform: methanol =
According to 2: 1), galactosylceramide can be obtained. Further, sphingomyelin can be obtained by separating the above galactosylceramide and then changing the solvent to chloroform: methanol (1: 2). This was dissolved in ether: ethanol (98: 2), and then dissolved in 100 mM Tris-HCl buffer and phospholipase C.
(Manufactured by Sigma) and shaken at 30 ° C. for 3 hours. Thereafter, chloroform: methanol (2: 1) is added, the mixture is stirred, centrifuged, and the lower layer is dried under reduced pressure. Silica column chromatography (chloroform: methanol =
9: 1) to obtain ceramide separately. The component (b) used in the present invention may be obtained by a chemical synthesis method other than the above method, or may be obtained from a mammal, a plant, or a microorganism.
Lipid mixtures containing one or more of the components also include (b) the invention.
Can be used as an ingredient. [0008] One or more of the amount of the mevalonic acid lactone mevalonate component (a) to the skin external composition of the present invention, based on the total amount of the external composition for skin, 0.00
1 to 10% by weight (hereinafter abbreviated as wt%). The component (b) of the ceramide, galactosylceramide, the amount of one or more of sphingomyelin 0.001
It is within the range of 3.0 wt%. The dosage form of the composition for external application to the skin of the present invention is not particularly limited, and the dosage form of a normal external composition for skin such as cream, emulsion, lotion, ointment, powder and the like can be applied. can do. In the external composition for skin of the present invention, as other components, an emulsifier, an oily substance, a humectant, a fragrance, a preservative, an antioxidant, a coloring agent and the like can be appropriately compounded within a range that achieves the object of the present invention. . Hereinafter, the present invention will be described in detail based on examples and comparative examples. In the examples, (1) the method for measuring the turnover speed of the stratum corneum, (2) the method for measuring the effect of improving rough skin, (3) the method for measuring the effect of improving stratum corneum, and (4) the sensory test are as follows. . (1) Method for measuring the turnover speed of the stratum corneum Dansyl chloride, a fluorescent dye, was added to white vaseline in an amount of 5 wt.
% Ointment was prepared and applied to the skin of the forearm of 20 subjects by occlusion for 24 hours, and dansyl chloride was osmotically bonded to the stratum corneum. Thereafter, the test sample was applied to the same site twice a day (morning and evening), and the fluorescence of dansyl chloride was examined every day.
The number of days until the fluorescence disappeared was defined as the skin stratum corneum turnover speed. The measurement results were shown as an average of the number of days for each subject. In addition, the normal skin stratum corneum turnover is 1
4-16 days, but extends to around 18 days in aged skin. On the other hand, when the anti-aging effect appears, 12
It will be shortened to around days. (2) Method of Measuring the Effect of Improving Rough Skin The effect of continuous application for four weeks was examined on 20 middle-aged and elderly subjects having rough skin on the lower leg. That is, the test sample was applied twice a day (morning and evening) to the left lower leg test site of the subject, and the skin condition before and after the test was determined according to the criteria shown in Table 1 below. The lower leg on the right side was used as a control without applying the test sample. [Table 1] [0014] Then, comparing the judgment results of the test site and the control site before and after the test, if the degree of dryness of the skin is improved by two or more stages (for example: + →-, ++ → ±), “effective” is improved by one stage. In the case where there was no change, it was regarded as "slightly valid", and in the case where there was no change, it was regarded as "invalid". The test results were indicated by the number of subjects who became “effective” and “slightly effective”. (3) Method for measuring the effect of improving keratin (enhancing the exfoliative properties of keratinocytes) A scotch tape (Nichiban Mending Tape) was adhered to the skin of the test part before and after the start of the above-described measurement test for measuring rough skin, and When this was peeled off, the state of the keratinocytes attached to the tape was examined in detail by a scanning electron microscope,
The stratum corneum cell exfoliation was classified according to the criteria shown in Table 2 below, and the keratin improving effect was determined. [Table 2] Judgment is made when the difference between the evaluation point of the test site and that of the control site after continuous application for 4 weeks is 2 or more points is “valid”, 1 point or more is “slightly effective”, and 0 point is "Invalid". The test results were indicated by the number of subjects who became “effective” and “slightly effective”. (4) Sensory test (Beauty skin effect test) Female subjects complaining of rough skin, fine lines, dry skin, etc.
Test sample twice a day (morning and evening) for 20 persons 3
The coating was applied for 1 month, and the effect after 1, 2 and 3 months was evaluated.
In the test results, for each item of skin wettability, smoothness, and elasticity, the respondents answered that "skin was moistened", "skin became smooth", and "skin became taut" Indicated by the number of people. Examples 1-4, Comparative Examples 1-6 (skin cream) One or more components selected from the group consisting of (a) mevalonic acid and lactone mevalonate, and (b) ceramide, glucosylceramide, galactosylceramide and sphingo. One kind selected from myelin was blended as shown in Table 4, each skin cream was prepared with the composition shown in Table 3, and the above-described experiments were performed. (1) Composition Table 3 (2) Preparation Method After the above components (A) and (B) are uniformly heated and melted to a temperature of 80 ° C., the component (A) is poured into the component (B), followed by stirring and mixing. Next, the temperature was cooled to 30 ° C. while stirring to prepare a skin cream. It is considered that R (-)-mevalonic acid lactone blended in the skin cream coexists with R (-)-mevalonic acid by hydrolysis. (3) Characteristics Tables 4 and 5 show the results of various tests conducted on each skin cream. [Table 4] [Table 5] As shown in Tables 4 and 5, skin creams containing only (a) component mevalon or mevalonate lactone or (b) component ceramide, glucosylceramide, galactosylceramide and sphingomyelin in Comparative Examples 1 to 6 Does not provide sufficient effects in various properties. However, in Examples 1-4 of the present invention, (a) one or more of mevalonic acid and mevalonate lactone, and (b) component ceramide, glucosylceramide, galactosylceramide, A skin cream that is used in combination with one or more sphingomyelins has a remarkable effect on improving rough skin, improving keratin, and increasing the turnover speed, that is, the effect of preventing skin aging. In addition, in the sensory test, two months after the application, it exhibited a beautiful skin effect excellent in expression and impartation of smoothness and elasticity in addition to wettability. Example 5, Comparative Examples 7 to 9 (Nourishing Oil) Various nourishing oils were prepared according to the compositions shown in Table 6 below, and various tests were conducted. (1) Composition (2) Preparation Method Nourishing oil was prepared by stirring and uniformly dissolving the components shown in Table 6 above. (3) Characteristics Table 7 shows the results of a sensory test conducted on each of the nourishing oils. [Table 7] As is clear from Table 7, the nourishing oil of the example exhibited a good skin effect two months after application. In addition, excellent skin aging prevention effect (rough skin improvement effect,
Keratin-improving effect, effect of increasing turnover speed). Example 6, Comparative Examples 10 to 12 (Skin Lotion) Each skin lotion was prepared according to the composition shown in Table 8 below, and various tests were carried out. (1) Composition (2) Preparation Method The components shown in Table 8 above were stirred and uniformly dissolved to prepare a skin lotion. (3) Characteristics Compared with Comparative Examples 10 to 12, the skin lotion of Example 6 has a superior skin effect and an effect of preventing skin aging (effects of improving rough skin, keratin, and increasing turnover speed). Indicated. Example 7 (Skin cream) A skin cream was prepared according to the composition shown in Table 9 below. [Table 9] (2) Preparation method The components (A) and (B) described in Table 9 were uniformly heated and dissolved to a temperature of 80 ° C. Next, after injecting and emulsifying the component (B) in the component (A), the mixture is stirred at 30 ° C.
Until cooled. Example 8 (Makeup Base) A makeup base was prepared according to the composition shown in Table 10 below. (1) Composition (2) Preparation method The components (A) and (B) shown in Table 10 were uniformly heated and dissolved to a temperature of 80 ° C. Next, the component (A) was injected and emulsified while stirring the component (B) with a homomixer, and then cooled to 30 ° C. Example 9 (Skin milk) Skin milk was prepared according to the composition shown in Table 11 below. (1) Composition (2) Preparation method The components (A) and (B) described in Table 11 were uniformly heated and dissolved to a temperature of 80 ° C. Next, after injecting and emulsifying the component (B) in the component (A), the mixture is stirred at 30 ° C.
Until cooled. The above Examples 7 to 9 exhibited excellent skin aging prevention effects (rough skin improvement effect, keratin improvement effect, effect of increasing turnover speed), and beautiful skin effect. EFFECT OF THE INVENTION As described above, the present invention is a useful external composition for skin which is excellent in skin aging prevention effect (rough skin improvement effect, keratin improvement effect, and turnover speed increase effect) and skin beautiful effect. It is clear that

───────────────────────────────────────────────────── フロントページの続き (58)調査した分野(Int.Cl.7,DB名) A61K 7/00 - 7/50 CA(STN) REGISTRY(STN)──────────────────────────────────────────────────続 き Continued on the front page (58) Field surveyed (Int. Cl. 7 , DB name) A61K 7/ 00-7/50 CA (STN) REGISTRY (STN)

Claims (1)

(57)【特許請求の範囲】 【請求項1】 (a)メバロン酸、メバロン酸ラクトン
から選ばれる一種以上を0.001〜10重量%と、
(b)セラミドガラクトシルセラミド、スフィンゴミ
エリンから選ばれる一種以上を0.001〜3.0重量
とを含有することを特徴とする皮膚外用組成物。
(57) [Claims 1] (a) 0.001 to 10% by weight of at least one selected from mevalonic acid and lactone mevalonate;
(B) 0.001 to 3.0 weight of at least one selected from ceramide , galactosylceramide and sphingomyelin.
% Of the composition for external use on the skin, characterized in that:
JP04053996A 1996-02-02 1996-02-02 External composition for skin Expired - Lifetime JP3534933B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP04053996A JP3534933B2 (en) 1996-02-02 1996-02-02 External composition for skin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP04053996A JP3534933B2 (en) 1996-02-02 1996-02-02 External composition for skin

Publications (2)

Publication Number Publication Date
JPH09208419A JPH09208419A (en) 1997-08-12
JP3534933B2 true JP3534933B2 (en) 2004-06-07

Family

ID=12583265

Family Applications (1)

Application Number Title Priority Date Filing Date
JP04053996A Expired - Lifetime JP3534933B2 (en) 1996-02-02 1996-02-02 External composition for skin

Country Status (1)

Country Link
JP (1) JP3534933B2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101106925B1 (en) * 2003-10-02 2012-01-25 주식회사 두산 Composition for protecting skin
JP2005281257A (en) 2004-03-30 2005-10-13 Snow Brand Milk Prod Co Ltd Skin-beautifying agent
FR2911779B1 (en) * 2007-01-30 2009-04-24 Lvmh Rech COMPOSITION CONTAINING AMBER EXTRACT

Also Published As

Publication number Publication date
JPH09208419A (en) 1997-08-12

Similar Documents

Publication Publication Date Title
JP3670279B2 (en) Anti-acne composition containing polya cocos wolf fungus extract
JPH08208519A (en) Use of salicylic acid derivative as stabilizer for oil-in-water type emulsion
JP3383496B2 (en) Method for producing liquid crystal emulsion and liquid crystal emulsion composition obtained by the method
JP3922311B2 (en) Skin aging prevention cosmetics
JPH08283139A (en) Dermal preparation for external use
JP3193542B2 (en) Anti-aging skin cosmetics
JP3534933B2 (en) External composition for skin
JP3534945B2 (en) Skin cosmetics
JP2001010946A (en) Skin cosmetic
DE102005023636A1 (en) Active ingredient combinations of glucosylglycerides and creatine and / or creatinine
FR2728465A1 (en) COSMETIC OR PHARMACEUTICAL COMPOSITION, IN PARTICULAR DERMATOLOGICAL, CONTAINING A SMELOPHYLLUM CAPENSE EXTRACT
JPS60184005A (en) Cosmetic for preventing aging of skin
JP3534941B2 (en) Anti-aging skin cosmetics
JPH10175843A (en) Cosmetic for skin
JPH11180851A (en) Skin cosmetic
JP3534934B2 (en) Skin cosmetics
JP3534947B2 (en) External preparation for skin
JPH06192658A (en) Cosmetic composition
JP2995014B2 (en) Skin cosmetics
JP3121957B2 (en) Anti-aging skin cosmetics
JPS6239511A (en) Cosmetic for preventing aging of skin
JP2002308791A (en) Ceramidase activity inhibitor, skin care preparation containing the activity inhibitor, cosmetic, and quasi-drug
JPH062661B2 (en) Skin cosmetics
JPH05194179A (en) Skin cosmetic
DE60212474T2 (en) Use of alkyl 3- (N-alkylacetamino) propionate derivatives as humectants

Legal Events

Date Code Title Description
TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20040309

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20040310

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313113

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313113

R371 Transfer withdrawn

Free format text: JAPANESE INTERMEDIATE CODE: R371

S531 Written request for registration of change of domicile

Free format text: JAPANESE INTERMEDIATE CODE: R313531

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313113

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20080319

Year of fee payment: 4

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090319

Year of fee payment: 5

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090319

Year of fee payment: 5

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100319

Year of fee payment: 6

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100319

Year of fee payment: 6

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110319

Year of fee payment: 7

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110319

Year of fee payment: 7

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120319

Year of fee payment: 8

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120319

Year of fee payment: 8

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130319

Year of fee payment: 9

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130319

Year of fee payment: 9

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20140319

Year of fee payment: 10

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

EXPY Cancellation because of completion of term